RALA Peptide

<strong>RALA Peptide</strong>_x000D_ <strong>Catalog number:</strong> B2019179_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 1 mg_x000D_ <strong>Molecular Weight or Concentration:</strong> N/A_x000D_ <strong>Supplied as:</strong> Powder_x000D_ <strong>Applications:</strong> a molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> -20°C_x000D_ <strong>Keywords:</strong> RALA Peptide_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: McCrudden CM, Bennie L, Chambers P, Wilson J, Kerr M, Ziminska M, Douglas H, Kuhn S, Carroll E, O'Brien G, Buckley N, Dunne NJ, McCarthy HO. Peptide delivery of a multivalent mRNA SARS-CoV-2 vaccine J Control Release. 2023 Oct;362:536-547._x000D_ 2: Bennett R, Yakkundi A, McKeen HD, McClements L, McKeogh TJ, McCrudden CM, Arthur K, Robson T, McCarthy HO. RALA-mediated delivery of FKBPL nucleic acid therapeutics Nanomedicine (Lond). 2015 Oct;10(19):2989-3001._x000D_ 3: Bombin ADJ, Dunne N, McCarthy HO. Delivery of a peptide/microRNA blend via electrospun antimicrobial nanofibres for wound repair Acta Biomater. 2023 Jan 1;155:304-322._x000D_ 4: O'Doherty M, Mulholland EJ, Chambers P, Pentlavalli S, Ziminska M, Chalanqui MJ, Pauly HM, Sathy BN, Donahue TH, Kelly DJ, Dunne N, McCarthy HO. Improving the Intercellular Uptake and Osteogenic Potency of Calcium Phosphate via Nanocomplexation with the RALA Peptide Nanomaterials (Basel). 2020 Dec 7;10(12):2442._x000D_ 5: McErlean EM, McCrudden CM, McBride JW, Cole G, Kett VL, Robson T, Dunne NJ, McCarthy HO. Rational design and characterisation of an amphipathic cell penetrating peptide for non-viral gene delivery Int J Pharm. 2021 Mar 1;596:120223._x000D_ 6: Chambers P, Ziminska M, Elkashif A, Wilson J, Redmond J, Tzagiollari A, Ferreira C, Balouch A, Bogle J, Donahue SW, Dunne NJ, McCarthy HO. The osteogenic and angiogenic potential of microRNA-26a delivered via a non-viral delivery peptide for bone repair J Control Release. 2023 Oct;362:489-501._x000D_ 7: Graham JP, Castro JG, Werba LC, Fardone LC, Francis KP, Ramamurthi A, Layden M, McCarthy HO, Gonzalez-Fernandez T. Versatile Cell Penetrating Peptide for Multimodal CRISPR Gene Editing in Primary Stem Cells bioRxiv [Preprint]. 2024 Sep 23:2024.09.23.614499._x000D_ 8: Jain AK, Massey A, Yusuf H, McDonald DM, McCarthy HO, Kett VL. Development of polymeric-cationic peptide composite nanoparticles, a nanoparticle-in-nanoparticle system for controlled gene delivery Int J Nanomedicine. 2015 Nov 24;10:7183-96._x000D_ 9: McCrudden CM, McBride JW, McCaffrey J, McErlean EM, Dunne NJ, Kett VL, Coulter JA, Robson T, McCarthy HO. Gene therapy with RALA/iNOS composite nanoparticles significantly enhances survival in a model of metastatic prostate cancer Cancer Nanotechnol. 2018;9(1):5._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/34443195">10: Liu Y, Wan HH, Tian DM, Xu XJ, Bi CL, Zhan XY, Huang BH, Xu YS, Yan LP. Development and Characterization of High Efficacy Cell-Penetrating Peptide via Modulation of the Histidine and Arginine Ratio for Gene Therapy Materials (Basel). 2021 Aug 19;14(16):4674. </a>_x000D_ _x000D_ <strong>Products Related to RALA Peptide can be found at</strong> <a href="https://moleculardepot.com/product-category/Proteins/"> Proteins</a>